Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
about
Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsementNovel Immunotherapeutic Approaches for Head and Neck Squamous Cell CarcinomaEarly direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic reviewPopulation-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisCervical cancer prevention in Australia: Planning for the futureHuman papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.Genital human papillomavirus infection among women in Bangladesh: findings from a population-based surveyHuman papillomavirus vaccination: the population impact.Educational interventions to increase HPV vaccination acceptance: a systematic review.The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents.Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesionsEvaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan AfricaMapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.Thank You, Edward. Merci, LouisAssociations Between Exposure to and Expression of Negative Opinions About Human Papillomavirus Vaccines on Social Media: An Observational StudyThe impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark.Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use.Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, AustraliaDeterminants of geographic inequalities in HPV vaccination in the most populated region of France.Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013.Study of 2 years follow-up of referral patients with abnormal Pap smearUS assessment of HPV types in cancers: implications for current and 9-valent HPV vaccinesParents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccinesLess than 3 doses of the HPV vaccine - Review of efficacy against virological and disease end points.Why don't adolescents finish the HPV vaccine series? A qualitative study of parents and providers.Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls.An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girlsEffect of human papillomavirus vaccination on cervical cancer screening in Alberta.Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based studyEndocervical Carcinogenesis and HPV Vaccination: An Occasional Circumstance or a Gap in the Chain?Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia.Declines in HPV-associated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, US, 2008-2015.Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer.Human papillomavirus vaccination: where are we now?Factors impacting HPV vaccination: lessons for health care professionals.Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.Cervical cancer screening at crossroads.Recent progress in vaccination against human papillomavirus-mediated cervical cancer.Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
P2860
Q28069669-4E894FEE-499B-4A03-81BA-AA50E153704DQ28071998-517AB235-6CBC-4914-863D-80CE18CF224FQ28081927-D8258119-5905-489E-B2E2-EE95F83E2E25Q28084924-3CD53454-2EAF-4E90-BDEC-93555D170093Q28270412-AB5DF15B-88EF-47DF-A94B-E09FC3E6EFFDQ30301333-4A83EAE0-BA1A-475E-8C7E-C09F891190D5Q30856793-9D46AEB1-8477-4B39-B3AD-CA4F1A5638E5Q33806566-B6D79C8F-CD32-4361-AF3A-348EDF85E389Q34846745-B24230E5-C354-4594-88D6-DC1C3C676AA5Q35078557-0581D24B-79B9-4A5E-BF31-D536C7F6059DQ35756579-3948F56A-7661-4046-9ADE-453CF70640E0Q35887646-12FD5C59-E3AB-46F6-9DAD-A221A0CF0B06Q35888255-555B1C65-8E56-4870-A0CF-65D068EF6F13Q35893932-19AA3CEF-65D5-4FBB-8355-2FDC0A3B3A4EQ35922347-1EB6A087-274F-40A3-BCA4-1819F734280CQ35959884-457FAEFC-34DE-477A-A360-605C8193CD9BQ35997434-528F9904-AD1D-4A14-A5CE-1D71502ACBB5Q35998533-C8F45ABA-D8DF-42BE-AD1E-C5759BDDBD0FQ36114121-012B643E-F26F-4EA9-A156-5C5CA0D4C29EQ36296590-8DBC9F5A-D9E6-430C-B225-E51DDB8E0BD0Q36418117-6A7050D7-358E-44EB-9DFA-F1125A60436DQ36616813-E4CC136B-70E5-4F07-A962-E1E92FBE9907Q36817074-DEF6A060-8B98-4DFA-B9C2-E0685A63BB8DQ37134945-DC957DAB-5151-4B8E-ACD0-BD122A4627CCQ37135074-9CFF7510-ABFD-4526-B405-C20AAC1DD7FBQ37135197-D1D68B22-39CF-4B8F-A569-8CF80DB45802Q37135216-1A37C61D-A02F-4C7F-B428-02DF49FE7A11Q37135276-9722B5F6-AB76-471B-8585-872D1DF4D6FEQ37227066-D76FAEFD-2366-45D8-9469-8F6174E1706BQ37349077-97A228DE-C535-431F-A70F-46227F4CEEF5Q37587340-BF860F26-88CB-4759-ABC9-1899C6CA8338Q37616577-760499DC-1B11-4DB6-9EB6-E48828A0DB06Q37834158-64697C7A-7227-4F57-B862-E39B40C51E2CQ38182714-C1881140-FEA9-4E4A-89B4-47E695B884C1Q38218612-DE811BA3-250E-4235-952A-EBE2B7F61613Q38223242-1FEB7DDA-9AA6-4C5F-B88F-38BB2C179900Q38229304-0484B759-3405-4AE5-AB33-22539DF1C8EAQ38232145-AB06ED40-253B-48B5-B02E-5FFA271D30B8Q38370782-6F434489-7D44-42BA-B373-78F965CB869FQ38373388-D2D789F8-E5B1-4553-8C6F-37033BFD0064
P2860
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Impact of a population-based H ...... alities: a data linkage study.
@ast
Impact of a population-based H ...... alities: a data linkage study.
@en
type
label
Impact of a population-based H ...... alities: a data linkage study.
@ast
Impact of a population-based H ...... alities: a data linkage study.
@en
prefLabel
Impact of a population-based H ...... alities: a data linkage study.
@ast
Impact of a population-based H ...... alities: a data linkage study.
@en
P2093
P2860
P356
P1433
P1476
Impact of a population-based H ...... alities: a data linkage study.
@en
P2093
A Marion Saville
Alison C Budd
Dorota M Gertig
Genevieve Chappell
Julia M L Brotherton
Kelly Drennan
P2860
P2888
P356
10.1186/1741-7015-11-227
P407
P577
2013-10-22T00:00:00Z
P5875
P6179
1037281520